NO20065701L - Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin - Google Patents

Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin

Info

Publication number
NO20065701L
NO20065701L NO20065701A NO20065701A NO20065701L NO 20065701 L NO20065701 L NO 20065701L NO 20065701 A NO20065701 A NO 20065701A NO 20065701 A NO20065701 A NO 20065701A NO 20065701 L NO20065701 L NO 20065701L
Authority
NO
Norway
Prior art keywords
oromucosal
agomelatine
pharmaceutical composition
sublingual administration
orodispersible pharmaceutical
Prior art date
Application number
NO20065701A
Other languages
English (en)
Norwegian (no)
Inventor
Patrick Wuthrich
Marc Julien
Francois Tharrault
Jean-Manuel Pean
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36663148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20065701(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20065701L publication Critical patent/NO20065701L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • A61K9/2826Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20065701A 2005-12-14 2006-12-11 Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin NO20065701L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0512647A FR2894475B1 (fr) 2005-12-14 2005-12-14 Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine

Publications (1)

Publication Number Publication Date
NO20065701L true NO20065701L (no) 2007-06-15

Family

ID=36663148

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065701A NO20065701L (no) 2005-12-14 2006-12-11 Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin

Country Status (41)

Country Link
US (1) US7892575B2 (es)
EP (1) EP1800669B1 (es)
JP (2) JP4996225B2 (es)
KR (3) KR20070063420A (es)
CN (2) CN101919800A (es)
AP (1) AP2714A (es)
AR (1) AR058332A1 (es)
AT (1) ATE474561T1 (es)
AU (1) AU2006252051B2 (es)
BR (1) BRPI0605214A (es)
CA (1) CA2571202C (es)
CO (1) CO5770094A1 (es)
CR (1) CR8788A (es)
CU (1) CU23603B7 (es)
CY (1) CY1110824T1 (es)
DE (1) DE602006015592D1 (es)
DK (1) DK1800669T3 (es)
EA (1) EA013751B1 (es)
ES (1) ES2348994T3 (es)
FR (1) FR2894475B1 (es)
GE (1) GEP20084509B (es)
GT (1) GT200600500A (es)
HK (1) HK1101802A1 (es)
HN (1) HN2008000874A (es)
HR (1) HRP20100517T1 (es)
IL (1) IL180036A0 (es)
MA (1) MA28722B1 (es)
MX (1) MXPA06014605A (es)
MY (1) MY143221A (es)
NO (1) NO20065701L (es)
NZ (1) NZ552025A (es)
PE (1) PE20071030A1 (es)
PL (1) PL1800669T3 (es)
PT (1) PT1800669E (es)
RS (1) RS51452B (es)
SG (1) SG133531A1 (es)
SI (1) SI1800669T1 (es)
TW (1) TWI327911B (es)
UA (1) UA86622C2 (es)
WO (1) WO2007068829A1 (es)
ZA (1) ZA200610511B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008008801A2 (en) * 2006-07-11 2008-01-17 Mcneil Nutritionals, Llc Solid oral dosage vitamin and mineral compositions
SI2238974T1 (sl) 2009-04-09 2013-09-30 E-Pharma Trento S.P.A. Granulat za formuliranje orodisperzibilnih tablet
CN101781226B (zh) * 2009-12-23 2012-03-28 天津泰普药品科技发展有限公司 阿戈美拉汀及其药物组合物
WO2011111027A2 (en) 2010-03-11 2011-09-15 Dexcel Pharma Technologies Ltd. Oral dispersible delayed release tablet formulation
CN101836966A (zh) * 2010-05-27 2010-09-22 北京万全阳光医药科技有限公司 一种含有阿戈美拉汀的口腔崩解片
CN101991559B (zh) * 2010-11-25 2012-04-18 天津市汉康医药生物技术有限公司 一种稳定的阿戈美拉汀胶囊药物组合物
US8426461B2 (en) 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
JP5600747B2 (ja) * 2011-01-17 2014-10-01 武田薬品工業株式会社 口腔内分散性製剤
FR2978916B1 (fr) 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
WO2013054582A1 (en) 2011-10-14 2013-04-18 Takeda Pharmaceutical Company Limited Orally dispersible tablet
CN103169669B (zh) * 2011-12-26 2015-06-17 中国人民解放军军事医学科学院毒物药物研究所 阿戈美拉汀包衣微丸以及可在口中分散的药物组合物
CN102552211B (zh) * 2012-02-16 2013-07-17 福建广生堂药业股份有限公司 一种阿戈美拉汀的制剂组合物及其制备方法
FR3000896B1 (fr) * 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
FR3001894A1 (fr) 2013-02-08 2014-08-15 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
PL2810656T3 (pl) * 2013-06-06 2018-01-31 Zentiva Ks Preparaty agomelatyny zawierające agomelatynę w postaci kokryształów
MX2015006022A (es) * 2014-02-07 2015-10-14 Scilabs Pharmaceuticals Sistemas de administracion de farmacos sublinguales, totalmente naturales, no toxicos.
CN104523639B (zh) * 2014-12-11 2017-03-22 扬子江药业集团四川海蓉药业有限公司 一种阿戈美拉汀片剂及其制备方法
NL2031332B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of psychoactive compounds
NL2031331B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of a short-acting psychedelic compound

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
ES2292414T3 (es) * 2000-07-27 2008-03-16 Roquette Freres Granulos a base de almidon y de lactosa.
JP2002338500A (ja) * 2001-03-15 2002-11-27 Yamanouchi Pharmaceut Co Ltd 苦味を低減した口腔内速崩壊錠および苦み低減化方法
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine

Also Published As

Publication number Publication date
GT200600500A (es) 2007-07-25
PL1800669T3 (pl) 2010-12-31
CR8788A (es) 2008-08-21
CU20060243A7 (es) 2009-09-08
MXPA06014605A (es) 2009-02-11
ZA200610511B (en) 2008-05-28
ES2348994T3 (es) 2010-12-21
CN1981752A (zh) 2007-06-20
MA28722B1 (fr) 2007-07-02
FR2894475B1 (fr) 2008-05-16
EP1800669B1 (fr) 2010-07-21
IL180036A0 (en) 2008-01-20
CN101919800A (zh) 2010-12-22
CA2571202C (fr) 2012-01-10
CA2571202A1 (fr) 2007-06-14
EA200602104A1 (ru) 2007-06-29
PE20071030A1 (es) 2007-11-17
TWI327911B (en) 2010-08-01
EP1800669A1 (fr) 2007-06-27
ATE474561T1 (de) 2010-08-15
AR058332A1 (es) 2008-01-30
HRP20100517T1 (hr) 2010-10-31
HK1101802A1 (en) 2007-10-26
UA86622C2 (ru) 2009-05-12
CU23603B7 (es) 2010-12-08
US7892575B2 (en) 2011-02-22
AU2006252051B2 (en) 2013-03-14
GEP20084509B (en) 2008-10-10
KR20080108068A (ko) 2008-12-11
CO5770094A1 (es) 2007-06-29
CY1110824T1 (el) 2015-06-10
KR101013667B1 (ko) 2011-02-10
SG133531A1 (en) 2007-07-30
AP2714A (en) 2013-07-31
SI1800669T1 (sl) 2010-11-30
KR20100012858A (ko) 2010-02-08
PT1800669E (pt) 2010-08-17
AU2006252051A1 (en) 2007-06-28
FR2894475A1 (fr) 2007-06-15
HN2008000874A (es) 2012-02-27
BRPI0605214A (pt) 2007-10-09
TW200738230A (en) 2007-10-16
MY143221A (en) 2011-03-31
DK1800669T3 (da) 2010-10-25
WO2007068829A1 (fr) 2007-06-21
DE602006015592D1 (de) 2010-09-02
RS51452B (en) 2011-04-30
EA013751B1 (ru) 2010-06-30
NZ552025A (en) 2008-12-24
CN1981752B (zh) 2011-11-02
KR20070063420A (ko) 2007-06-19
US20070134331A1 (en) 2007-06-14
AP2006003844A0 (en) 2006-12-31
JP4996225B2 (ja) 2012-08-08
JP2007182440A (ja) 2007-07-19
JP2012092132A (ja) 2012-05-17

Similar Documents

Publication Publication Date Title
NO20065701L (no) Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
TW200621313A (en) Pharmaceutical compositions
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
EA200802444A1 (ru) Стабилизированные фармацевтические композиции, содержащие фезотеродин
NO20043367L (no) Oralt farmasoytisk preparat
BRPI0716171A2 (pt) composto, composiÇço farmacÊutica e uso de um composto.
EA200702198A1 (ru) Фармацевтические составы
NO20080991L (no) Bazedoksifen acetat formuleringer
ATE303149T1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
BRPI0408895A (pt) formulações de cladribina para administração oral e transmucosal aperfeiçoada
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
DK1971216T3 (da) Tyggegummi indeholdende styren-dien-blokcopolymerer
MA32834B1 (fr) 3-aminocyclopentanecarboxamides servant de modulateurs de recepteurs de chimiokines
CL2007002812A1 (es) Compuestos derivados de quinolina; composicion farmaceutica, utiles para inhibir el vih.
DE602007005387D1 (de) Ptors
ATE537816T1 (de) Leflunomid enthaltende pharmazeutische zusammensetzungen
EA200870236A1 (ru) Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе
CR10098A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
BRPI0820659A2 (pt) composto, prodroga de composto, composição farmacêutica e formulação oral e uso de composto.
IT1356828B (it) Composizione, particolarmente per la preparazione di malte cementizie.
CL2008003918A1 (es) Compuesto derivado de gama-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico, dispositivo intrauterino que lo contiene y su uso para la contracepcion oral y para trastornos pre, peri y postmenopausicos.
UY30085A1 (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion su aplicacion en terapeutica
TNSN06396A1 (fr) Compositions pharmaceutiques orodispersible pour administration oromucosale ou sublinguale d'agomelatine
UY30005A1 (es) Composicion farmaceutica orodispersable para la administracion oral/mucosa o sublingual de la agomelatina.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application